FibroBiologics, Inc.FibroBiologics, Inc.FibroBiologics, Inc.

FibroBiologics, Inc.

No trades
See on Supercharts
Market capitalization
‪308.54 M‬USD
‪−16.49 M‬USD
‪26.55 M‬
Beta (1Y)
−2.17

About FibroBiologics, Inc.

CEO
Peter O'Heeron
Headquarters
Houston
Employees (FY)
10
Founded
2021
FIGI
BBG01K4MB400
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of FBLG is 7.93 USD — it has decreased by 15.91% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange FibroBiologics, Inc. stocks are traded under the ticker FBLG.
FBLG stock is 23.04% volatile and has beta coefficient of −2.17. Check out the list of the most volatile stocks — is FibroBiologics, Inc. there?
Yes, you can track FibroBiologics, Inc. financials in yearly and quarterly reports right on TradingView.
FBLG stock has fallen by 26.03% compared to the previous week, the month change is a 26.78% fall, over the last year FibroBiologics, Inc. has showed a 73.57% decrease.
FBLG net income for the last quarter is ‪−9.72 M‬ USD, while the quarter before that showed ‪−2.19 M‬ USD of net income which accounts for −343.29% change. Track more FibroBiologics, Inc. financial stats to get the full picture.
No, FBLG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, FBLG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FibroBiologics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
FBLG reached its all-time high on Jan 31, 2024 with the price of 55.00 USD, and its all-time low was 6.53 USD and was reached on Feb 12, 2024.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 10.00 employees. See our rating of the largest employees — is FibroBiologics, Inc. on this list?